Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00552097
Show Display Options
Rank Status Study
1 Completed Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)
Conditions: Atherosclerosis;   Hypercholesterolemia;   Hyperlipoproteinemia Type II
Interventions: Drug: ezetimibe (plus simvastatin);   Drug: placebo (plus simvastatin)

Indicates status has not been verified in more than two years